Delivery Order SPE2DU25D9439-SPE2DU26FEEHC
Award Date 5/11/26
Potential Completion Date 5/14/26
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $4,405.20 delivery order to DMS Pharmaceutical Group Inc. on May 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to Department of Defense military healthcare facilities. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. DMS Pharmaceutical is the sole regional prime vendor authorized to issue...
- The Defense Logistics Agency issued a $19,332.22 delivery order to DMS Pharmaceutical Group Inc. on April 20, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to military healthcare facilities. PPV-G GEN V is a single-award indefinite delivery contract with a $499.999 billion ceiling through December 31, 2036, structured with a 30-month base period and three 30-month option periods. DMS Pharmaceutical is the sole regional prime...
- The Defense Logistics Agency issued a $24,132.70 delivery order to DMS Pharmaceutical Group Inc. on May 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities. PPV-G GEN V is a $30.3 billion acquisition strategy structured with a 30-month base period and three 30-month option periods, with DMS Pharmaceutical as the sole regional prime vendor...
- The Defense Logistics Agency issued a $19,332.22 delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to Department of Defense military healthcare facilities. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. DMS Pharmaceutical is the sole regional prime vendor...
- The Defense Logistics Agency issued a $277,345.48 delivery order to DMS Pharmaceutical Group Inc. on May 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract for pharmaceutical products and medical consumables. PPV-G GEN V is a single-award Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. DMS Pharmaceutical is the sole regional prime vendor authorized to issue...
- The Defense Logistics Agency issued a $17,628.86 delivery order to DMS Pharmaceutical Group Inc. on April 21, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to military healthcare facilities. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. DMS Pharmaceutical Group Inc. is a woman-owned small business and the sole regional prime...
- The Defense Logistics Agency issued a $11,344.26 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 13, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for branded and generic prescription drugs, biologics, over-the-counter medications, vaccines, and medical consumables supporting Department of Defense...
- The Defense Logistics Agency issued a $33,168.26 delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036, under which DMS Pharmaceutical serves as the sole regional prime vendor authorized to issue firm...
- The Defense Logistics Agency issued a $28,075.32 delivery order to DMS Pharmaceutical Group Inc. on May 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to Department of Defense military healthcare facilities. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036. DMS Pharmaceutical is the sole regional prime vendor authorized to issue...
- The Defense Logistics Agency issued a $1,774.84 delivery order to DMS Pharmaceutical Group Inc. on May 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply to military healthcare facilities. DMS Pharmaceutical Group Inc. is a woman-owned small business. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract framework with a $499.999 billion ceiling and ultimate completion date of December 31, 2036,...